Open menu

Nanotechnology Business News

The latest product and company news

Patent Grant For Nanoscience Inc.

Nanoscience Inc., the specialist niche investor in emerging technologies with strong commercial propositions from within the growing nanotechnology sector, is pleased to announce that its wholly owned subsidiary, Toumaz Technology Limited has been granted its core patent surrounding the AMx (Advanced Mixed Signal) technology in the key jurisdiction of Australia.

Posted: Dec 12th, 2007

Read more

Copernicus Receives Milestone Payment from Cystic Fibrosis Foundation Therapeutics

Copernicus Therapeutics, Inc. announced today that it received a milestone payment from Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), a non-profit affiliate of the Cystic Fibrosis Foundation. This milestone payment is part of a research, development, and commercialization agreement between CFFT and Copernicus to develop gene therapy to treat cystic fibrosis.

Posted: Dec 11th, 2007

Read more

Switzerland Woos Indian Companies

Aiming at major foreign investments from India in Switzerland, the Swiss government promises the country to be a major trading hub for Indian companies in the next 10-12 years.

Posted: Dec 11th, 2007

Read more

Nanogen, Inc. Files Preliminary Proxy Statement

Nanogen, Inc., developer of advanced diagnostic products, announced that it has filed with the Securities and Exchange Commission a preliminary proxy statement for a special meeting of its stockholders.

Posted: Dec 10th, 2007

Read more

Nanogen Reaches Milestone in CDC Influenza Project

Nanogen, Inc., developer of advanced diagnostic products, announced today that it has delivered the second phase milestone requirements, including the point-of-care prototype device to detect influenza viruses rapidly in clinical samples, to the Center for Disease Control and Prevention for their evaluation.

Posted: Dec 10th, 2007

Read more

Valutek Donation Supports TGen's Genomic Research and Discovery Programs

Valutek, a leading solutions provider of products for cleanrooms and controlled environments, has made a $10,000 product donation to the Translational Genomics Research Institute. The contribution actively supports Phoenix's burgeoning biotech movement and directly benefits TGen's research initiatives.

Posted: Dec 8th, 2007

Read more